Thus, it is reasonable to speculate that the aberrant expression patterns of Nqo-AS1 and Nqo1 mRNA in PBMCs from patients with COPD might represent the CS-induced oxidative damage to innate and adaptive immunity cells of patients with COPD to some extent. The gene discussed is NQO1; the disease is chronic obstructive pulmonary disease.